Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Other Non-current Assets
Long-term assets not reported separately.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Other Non-current Assets · Q4 FY2024 · quarter ended Mar 2025
Other non-current assets rises 760.3% from a year ago
Other non-current assets stood at $700.64K at the end of Q4 FY2024, up 760.3% from a year earlier.
Context
- Other non-current assets amounted to 13.1% of total assets at the end of Q4 FY2024, up 11.4 pp from a year earlier.
- Other non-current assets increased in 1 of the last 2 fiscal years.
- FY2024 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether other non-current assets keeps rising in the next quarterly balance sheet after a +760.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2024
- 700.64K USD
- Year-over-year change
- +760.3%
- 2-year CAGR
- +90.2%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 700.64K | +760.3% |
| FY2023 | 2024-03-31 | 81.44K | -58.0% |
| FY2022 | 2023-03-31 | 193.75K | — |
Other Non-current Assets vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 other non-current assets of $700.64K is the 7th highest of the 10 companies compared; the peer median is $1.78M.
- Its year-over-year change of +760.3% is the 3rd highest of 9, against a peer median of +44.3%.
- Other non-current assets amounts to 13.1% of total assets for MCTA, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $19.04M | -75.9% | -48.8% | 1.3% | |
| Feb 2026 | $18.17M | +3892.5% | +47.2% | 12.4% | |
| Mar 2026 | $10.19M | +34.6% | -9.9% | 3.7% | |
| Mar 2026 | $9.75M | +54.0% | +110.2% | 3.7% | |
| Mar 2026 | $1.78M | +54.3% | -4.3% | 0.6% | |
| Mar 2026 | $1.76M | -95.2% | +22.5% | 0.4% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $700.64K | +760.3% | — | 13.1% |
| Mar 2026 | $620K | +4.9% | +8.3% | 0.4% | |
| Mar 2026 | $186K | +859.0% | +232.7% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MCTA) | $1.78M | +44.3% | +15.4% | 0.6% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.